The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.

Amwell, a US-based telehealth technology provider backed by electronics and medical technology producer Philips, insurance group Allianz and pharmaceutical firms Teva and Takeda, will raise $742m in its initial public offering today. The company has increased the number of shares in the offering from 35 million to 41.2 million and priced them at $18.00, above…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.